Electrophysiologic effects, efficacy and tolerance of class Ic antiarrhythmic agents in Wolff-Parkinson-White syndrome.
Manolis
A S
AS
Department of Medicine, Tufts University School of Medicine, Boston, Massachusetts 02111.
Salem
D N
DN
Estes
N A
NA
D000328:Adult; D000368:Aged; D000813:Anilides / Q000627:therapeutic use*; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D002304:Cardiac Pacing, Artificial; D004361:Drug Tolerance; D004562:Electrocardiography; D004594:Electrophysiology; D016700:Encainide; D005260:Female; D005424:Flecainide / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006329:Heart Conduction System / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D013997:Time Factors; D014927:Wolff-Parkinson-White Syndrome / Q000188:drug therapy*
D000813:Anilides; D000889:Anti-Arrhythmia Agents; D005424:Flecainide; D016700:Encainide